Circulating Tumor DNA Analyses as a Potential Marker of Recurrence and Effectiveness of Adjuvant Chemotherapy for Resected Non-Small-Cell Lung Cancer

BACKGROUND: Although adjuvant chemotherapy is established for patients with non-small-cell lung cancer (NSCLC), the long-term survival remains to be improved. Postsurgical circulating tumor DNA (ctDNA) analysis of resectable NSCLC may identify patients at high risk of recurrence after adjuvant chemo...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuang, Peng-Peng, Li, Ning, Liu, Zui, Sun, Tian-Yu, Wang, Shu-Quan, Hu, Jia, Ou, Wei, Wang, Si-Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919598/
https://www.ncbi.nlm.nih.gov/pubmed/33659207
http://dx.doi.org/10.3389/fonc.2020.595650

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919598/
https://www.ncbi.nlm.nih.gov/pubmed/33659207
http://dx.doi.org/10.3389/fonc.2020.595650

Ejemplares similares